The OASIS project focusses on population-based surveillance of antimicrobial resistance. It is active in both the human and the veterinary domain. The current talk describes the project, elaborates on the smart sampling strategy it uses, and places it into context with other innovations in AMR-surveillance, including waste-water surveillance. The audience is global through the EMBARK network.